Randomized Assessment of the Safety and Efficacy of Intra-Arterial Infusion of Autologous Stem Cells in Subacute Ischemic Stroke [INTERVENTIONAL]
CONCLUSIONS:
Intra-arterial infusion of stem cells can be carried out safely in the subacute stage of ischemic stroke. Improved clinical outcomes were observed with intra-arterial stem cell therapy; however, studies with larger cohorts are needed to validate the results.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Bhatia, V., Gupta, V., Khurana, D., Sharma, R. R., Khandelwal, N. Tags: INTERVENTIONAL Source Type: research
More News: Brain | Hemorrhagic Stroke | Ischemic Stroke | Neurology | Stem Cell Therapy | Stem Cells | Stroke | Study